30 Jun, 2021 RNAi Roundtable: Zilebesiran (ALN-AGT), in Development for the Treatment of Hypertension
On June 30, 2021, we hosted an online RNAi Roundtable to review the progress with zilebesiran (ALN-AGT), an RNAi therapeutic in development for the treatment of hypertension.
Pushkal Garg, M.D.
Chief Medical Officer
Elizabeth Ofili, M.D., MPH, FACC
Professor of Medicine (Cardiology), Morehouse School of Medicine
Stephen Huang, M.D.
Senior Director, Clinical Research
Senior Vice President, Development Programs